Skip to main content
. 2012 Oct;97(10):1582–1585. doi: 10.3324/haematol.2012.064683

Figure 1.

Figure 1.

Proposal of a workflow for molecular diagnostics in patients with the suspicion for myeloproliferative or myelodysplastic/myeloproliferative disorders. MPN: myeloproliferative neoplasm; CML: chronic myeloid leukemia; PV: polycythemia vera; ET: essential thrombocythemia; PMF: primary myelofibrosis; CMML: chronic myelomonocytic leukemia.